A halt on exports of research animals threatens drug discovery; Roche CEO Bill Anderson to step down

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by         STAT+: Cambodia halts exports of non-human primates, threatening drug discovery efforts By Ed Silverman Courtesy Tulane National Primate Research Center "Depending on the duration of restrictions on imports. drug discovery and development in the US could be materially impacted" Inotiv said. Read More STAT+: Ongoing problems with a new European clinical trial registry could cause 'catastrophe' By Ed Silverman Molly Ferguson for STAT The problems plaguing new clinical trial registration systems "massively impaired and cannot be managed," several research groups wrote. Read More STAT+: Roche pharmaceuticals CEO Bill Anderson to step down after four-year tenure By Jason Mast SEBASTIEN BOZON/AFP via Getty Images In the last year, Roche watched two of its most closely watched drug candidates fail to yield results in late-stage trials. Read More Sponsored Insight by PHARMACYCLICS & JANSSEN ONCOLOGY 'No one will advocate for me better than myself': Hannah's story of living with CLL Hannah was leading an active lifestyle as a full-time employee, foster parent of six, wife and enthusiastic crafter when she received her diagnosis of chronic lymphocytic leukemia (CLL), an incurable form of blood cancer. After about a year of treatment, it became clear Hannah needed a second opinion to get back to her lifestyle. Read more about Hannah's journey and why she chose to advocate for herself. STAT+: Amgen's $27.8 billion Horizon merger is latest industry bet on pricey rare disease drugs By Matthew Herper and Jason Mast Ruby Wallau for STAT The largest pharma merger this year illustrates how expensive rare-disease drugs have become among the industry's most profitable bets. Read More Opinion: Responsibly expanding access to methadone for people with opioid use disorder will save lives By Greg Rudolf David Goldman/AP Unscientific regulations that limit access to methadone prevent many people with opioid use disorder from receiving this lifesaving medicine. Read More Monday, December 12, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser